<DOC>
	<DOCNO>NCT01880788</DOCNO>
	<brief_summary>The study design case control evaluation compare genetic profile three group patient categorize accord diagnosis . Group 1 - CNV secondary CSC Group 2 - CSC without CNV Group 3 - CNV secondary advance AMD .</brief_summary>
	<brief_title>Genetic Analysis Chronic Central Serous Chorioretinopathy Masquerading Neovascular AMD</brief_title>
	<detailed_description>To determine patient present type 1 neovascularization believe secondary CSC genetically distinct typical CSC patient without neovascularization patient present choroidal neovascularization ( CNV ) secondary advanced AMD . Disease associate marker detect variant ARMS 2 , Complement Factor H ( CFH ) Complement component 3 ( C3 ) , Complement component 2 ( C2 ) , Factor B ( FB ) , VEGFA genetic polymorphism associate CNV evaluate determine CSC neovascular group genetically distinct CSC group without neovascularization advance AMD group .</detailed_description>
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Choroidal Neovascularization</mesh_term>
	<mesh_term>Neovascularization , Pathologic</mesh_term>
	<mesh_term>Central Serous Chorioretinopathy</mesh_term>
	<criteria>Caucasian 30 year old ( CSC ) 50 year old ( Advanced AMD ) Genders Eligible Study : Both Completed Consent form Diagnosis choroidal neovascularization least one eye Patient age less 30 year ( CSC ) . Patient age le 50 year ( AMD ) . Presence retinal disease involve photoreceptors and/or out retinal layer AMD CSC high myopia , retinal dystrophy , retinal vein occlusion , diabetic retinopathy uveitis similar outer retinal disease present prior age 30 . Opacities ocular medium , limitation pupillary dilation problem sufficient preclude adequate fundus photography . Missing informed consent Previous sample donation protocol</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Age Related Macular Degeneration</keyword>
	<keyword>Choroidal Neovascularization</keyword>
	<keyword>Central Serous Chorioretinopathy</keyword>
</DOC>